Reuters logo
BRIEF-Kiadis Pharma announces initiation of Phase I/II clinical trial with ATIR201for thalassemia
December 15, 2016 / 6:25 AM / a year ago

BRIEF-Kiadis Pharma announces initiation of Phase I/II clinical trial with ATIR201for thalassemia

Dec 15 (Reuters) - Kiadis Pharma Nv :

* Kiadis Pharma announces initiation of a Phase I/II clinical trial with ATIR201for thalassemia

* Obtained regulatory approval from national authority in United Kingdom (MHRA, Medicines And Healthcare Products Regulatory Agency)

* New trial will commence in United Kingdom and company plans to expand trial into Germany pending regulatory approval

* Expects first safety and efficacy results to become available in second half of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below